ConductScience.org, home

Paper571963

Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells.

Farrell PJ and 2 others. Nature, 1979. Cited by 277 papers, by iCite.

Cite this record

ConductScience Library. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Papers, record 571963. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/571963

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells.
PubMed
Journal
Nature
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
277
iCite
Relative citation ratio, by iCite
4.54
iCite
Revised in PubMed
2022-04-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Farrell PJP J
2Broeze RJR J
3Lengyel PP

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Ehrlich TumorMajor topic
InterferonsMajor topic
Neoplasm ProteinsMajor topic
RNA, MessengerMajor topic
Animals
Cell-Free System
Isoelectric Point
Molecular Weight
RNA, Neoplasm

Source PubMed

Download CSV of topics

Cited by142

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 277 citations.

PMIDTitleJournalYearIn PapersSource
42884081ISG15 Is a Key Multidirectional Regulator of Cytosolic RNA- and DNA-Sensing Pathways and Type I Interferon Feedback Loops.Int J Mol Sci2026https://conductscience.org/library/papers/42884081PubMed
42652131RNF213 in Panvascular Disease: A Molecular Hub Linking Genetic Susceptibility to Systemic Vasculopathy.Biomedicines2026https://conductscience.org/library/papers/42652131PubMed
42442365Understanding protein ISGylation, a multifaceted posttranslational modification.Cell Chem Biol2026https://conductscience.org/library/papers/42442365PubMed
42303907SEMA6A inhibits tumor progression and boosts anti-tumor immunity via blocking the ISG15/TGFβ axis in colorectal cancer.Mol Biomed2026https://conductscience.org/library/papers/42303907PubMed
42111249The modifier matrix: emerging roles of ubiquitin-like proteins in Alzheimer's disease.Mol Neurodegener Adv2026https://conductscience.org/library/papers/42111249PubMed
42058221When ISG15 is involved in inflammation.Front Immunol2026https://conductscience.org/library/papers/42058221PubMed
42023152ISGylation is disrupted by UBA7 gene variants identified in individuals with neurodevelopmental disorder phenotypes.iScience2026https://conductscience.org/library/papers/42023152PubMed
41512080The OAS-RNase L pathway: Insights from experiments of nature.Sci Immunol2026https://conductscience.org/library/papers/41512080PubMed
41476985Temporal modulation of gene expression in a controlled Schistosoma mansoni human infection model.Front Immunol2025https://conductscience.org/library/papers/41476985PubMed
40904511Resolving tumor microenvironment heterogeneity to forecast immunotherapy response in triple-negative breast cancer through multi-scale analysis.Front Oncol2025https://conductscience.org/library/papers/40904511PubMed
40896734Houttuynia cordata triggers type I interferon signaling to promote host defense against Acinetobacter baumannii infection via mTORC1 activation.Biochem Biophys Rep2025https://conductscience.org/library/papers/40896734PubMed
40719862ISG-15, beyond its functions in the cell: a mini review.Cell Mol Life Sci2025https://conductscience.org/library/papers/40719862PubMed
40410283Spermidine reduces ISGylation and enhances ISG15-USP18 interaction.Sci Rep2025https://conductscience.org/library/papers/40410283PubMed
40353372Interferon-induced protein ISG15 in the central nervous system, quo vadis?FEBS Lett2025https://conductscience.org/library/papers/40353372PubMed
40103488ISGylation: is our genome yearning for such a modification?Acta Biochim Biophys Sin (Shanghai)2025https://conductscience.org/library/papers/40103488PubMed
39931755ISG15-Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in Humans.Eur J Immunol2025https://conductscience.org/library/papers/39931755PubMed
38891017The Effects of Smoking on Telomere Length, Induction of Oncogenic Stress, and Chronic Inflammatory Responses Leading to Aging.Cells2024https://conductscience.org/library/papers/38891017PubMed
38665231Interferons and interferon-related pathways in heart disease.Front Cardiovasc Med2024https://conductscience.org/library/papers/38665231PubMed
38594382Dynamic molecular network analysis of iPSC-Purkinje cells differentiation delineates roles of ISG15 in SCA1 at the earliest stage.Commun Biol2024https://conductscience.org/library/papers/38594382PubMed
38392865Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs.Pathogens2024https://conductscience.org/library/papers/38392865PubMed

See all 142 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/571963

GET https://conductscience.org/api/papers/v1/571963/cited_by?page=2